Dana Small Cap Equity
As of: August 29, 2018
Dana Epiphany Small Cap Equity Fund
Fund Information
as of 06/30/25
| SYMBOL | DSCIX |
| INCEPTION DATE | 11/2/15 |
| BENCHMARK | Morningstar Small Core Index |
| TOTAL FUND AUM | $29.2 MM |
| TOTAL FIRM AUM | $8.7 BN |
| MIN. INVESTMENT | $5,000 |
| NET EXPENSE RATIO | 0.95% |
| GROSS EXPENSE RATIO | 1.47% |
| NUMBER OF HOLDINGS | 60 – 65 |
| TARGET CASH POSITION | 0 – 1% |
| INDIVIDUAL SECURITY LIMIT | < 4% |
| SECTOR LIMITS | SECTOR NEUTRAL |
Data source: Morningstar Direct; The Adviser has contractually agreed to waive its management fee and/or reimburse certain operating expenses through 2/28/2026, so that Total Annual Operating Expenses does not exceed 0.95% for the Small Cap Fund.
Top Holdings
as of 06/30/25, subject to change. Current and future portfolio holdings are subject to risk.
| Evercore, Inc. Cl A | 2.32% |
| Fabrinet | 2.28% |
| Blueprint Medicines Corp. | 2.17% |
| e.l.f. Beauty, Inc. | 2.11% |
| SPX Technologies | 2.09% |
| Agilsys, Inc. | 2.08% |
| Synovus Financial Corp | 2.08% |
| Ensign Group | 2.04% |
| AXIS Capital Holdings Ltd. | 2.03% |
| Magnite, Inc. | 2.02% |